A Review published in Respiratory Research updates the current evidence regarding the role of vitamin D in airway inflammation and various respiratory diseases.
]. Findings were further confirmed in a randomized, double-blinded, placebo-controlled trial to determine whether vitamin D supplementation improved overall survival or relapse-free survival in the total study population or in relation to stage, pathology, or serum levels of 25D before vitamin D supplementation of 1200 IU for 12 months. Supplementation did not improve OS in the total studied population.
. Nonetheless, in recent studies, it has been shown that treatment such as Nivolumab, a monoclonal antibody which binds to anti-programmed cell death protein 1 can be affected by vitamin D concentrations prompting the suggestion to evaluate vitamin D levels prior to treatment [Acute lung injury and Acute respiratory distress syndrome remain a significant cause of morbidity and mortality in critically ill patients worldwide.
]. To date, no known therapy has proven to be beneficial in ALI/ARDS patients. Recent evidence shows an association between vitamin D deficiency and increased adverse outcomes in patients who develop ALI/ARDS. In a study by Dancer et al]. Moreover, in a mouse model of ARDS, dietary-induced vitamin D deficiency resulted in hypoxia, epithelial damage, and alveolar inflammation.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
RSV in children: Parents warned over signs of virusNorthern Ireland has seen a surge in respiratory syncytial virus, which usually causes colds in adults but can be fatal for babies and the elderly
Consulte Mais informação »
Scientists May Have Just Discovered A Lake On MarsA new study suggests that in the south Martian pole, there may be a lake buried beneath the ice. Here's what that means
Consulte Mais informação »
Alzheimer's Drug Shows Promise in Early Results of StudyShares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study
Consulte Mais informação »
Alzheimer's-slowing drug labelled historicTrial results of a drug appearing to slow Alzheimer's disease represent a 'historic moment', experts say.
Consulte Mais informação »
Aachen’s Center for Advanced Mobility is a celebration of technical innovationStudio MDA’s Center for Advanced Mobility in Aachen, Germany celebrates technical innovation and interdisciplinary collaboration
Consulte Mais informação »